Decreased CXCR3 Expression in CD4+T Cells Exposed to Asbestos or Derived from Asbestos-Exposed Patients

Interleukin-6 as a Therapeutic Target in Candidate Inflammatory Diseases

(2010) N Nishimoto   CLINICAL PHARMACOLOGY & THERAPEUTICS

The NLRP3 inflammasome, a target for therapy in diverse disease states

(2010) Graham P. Cook et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Up for Mischief? IL-17/Th17 in the tumour microenvironment

(2010) E Maniati et al.   ONCOGENE

Asbestos fibers in para-aortic and mesenteric lymph nodes

(2009) Toomas Uibu et al.   AMERICAN JOURNAL OF INDUSTRIAL MEDICINE

Clinical Use of Interferon-γ

(2009) Catriona H.T. Miller et al.   Annals of the New York Academy of Sciences

Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases

(2009) Shuko Murakami et al.   Environmental Health and Preventive Medicine

Characteristics and modifying factors of asbestos-induced oxidative DNA damage

(2008) Li Jiang et al.   CANCER SCIENCE

Cancer-related inflammation

(2008) Alberto Mantovani et al.   NATURE